tradingkey.logo

Apyx Medical Corp

APYX
查看詳細走勢圖
3.550USD
+0.060+1.72%
交易中 美東報價延遲15分鐘
134.26M總市值
虧損本益比TTM

Apyx Medical Corp

3.550
+0.060+1.72%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+1.72%

5天

-8.03%

1月

-11.25%

6月

+77.50%

今年開始到現在

+124.68%

1年

+126.11%

查看詳細走勢圖

TradingKey Apyx Medical Corp股票評分

單位: USD 更新時間: 2025-12-19

操作建議

Apyx Medical Corp當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名115/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為買入。最高目標價5.67。中期看,股價處於上升通道。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Apyx Medical Corp評分

相關信息

行業排名
115 / 208
全市場排名
273 / 4582
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 4 分析師
買入
評級
5.667
目標均價
+43.10%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Apyx Medical Corp亮點

亮點風險
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
業績增長期
公司處於發展階段,最新年度總收入48.10M美元
估值低估
公司最新PE估值-9.70,處於3年歷史低位
查克·羅伊斯持倉
明星投資者查克·羅伊斯持倉,最新持倉2.47M股

Apyx Medical Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Apyx Medical Corp簡介

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
公司代碼APYX
公司Apyx Medical Corp
CEOGoodwin (Charles D)
網址https://apyxmedical.com/

常見問題

Apyx Medical Corp(APYX)的當前股價是多少?

Apyx Medical Corp(APYX)的當前股價是 3.550。

Apyx Medical Corp 的股票代碼是什麼?

Apyx Medical Corp的股票代碼是APYX。

Apyx Medical Corp股票的52週最高點是多少?

Apyx Medical Corp股票的52週最高點是4.440。

Apyx Medical Corp股票的52週最低點是多少?

Apyx Medical Corp股票的52週最低點是0.755。

Apyx Medical Corp的市值是多少?

Apyx Medical Corp的市值是134.26M。

Apyx Medical Corp的淨利潤是多少?

Apyx Medical Corp的淨利潤為-23.46M。

現在Apyx Medical Corp(APYX)的股票是買入、持有還是賣出?

根據分析師評級,Apyx Medical Corp(APYX)的總體評級為買入,目標價格為5.667。

Apyx Medical Corp(APYX)股票的每股收益(EPS TTM)是多少

Apyx Medical Corp(APYX)股票的每股收益(EPS TTM)是-0.360。
KeyAI